Relay Therapeutics Statistics
Total Valuation
RLAY has a market cap or net worth of $1.23 billion. The enterprise value is $608.43 million.
Important Dates
The next confirmed earnings date is Thursday, November 6, 2025, after market close.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
RLAY has 172.41 million shares outstanding. The number of shares has increased by 26.88% in one year.
| Current Share Class | 172.41M |
| Shares Outstanding | 172.41M |
| Shares Change (YoY) | +26.88% |
| Shares Change (QoQ) | +1.20% |
| Owned by Insiders (%) | 2.18% |
| Owned by Institutions (%) | 61.20% |
| Float | 102.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 138.51 |
| Forward PS | 181.93 |
| PB Ratio | 1.84 |
| P/TBV Ratio | 1.85 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 72.82 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 20.92, with a Debt / Equity ratio of 0.05.
| Current Ratio | 20.92 |
| Quick Ratio | 20.19 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -46.24% and return on invested capital (ROIC) is -29.73%.
| Return on Equity (ROE) | -46.24% |
| Return on Assets (ROA) | -28.37% |
| Return on Invested Capital (ROIC) | -29.73% |
| Return on Capital Employed (ROCE) | -48.94% |
| Revenue Per Employee | $32,011 |
| Profits Per Employee | -$1.19M |
| Employee Count | 261 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +25.04% in the last 52 weeks. The beta is 1.75, so RLAY's price volatility has been higher than the market average.
| Beta (5Y) | 1.75 |
| 52-Week Price Change | +25.04% |
| 50-Day Moving Average | 5.25 |
| 200-Day Moving Average | 3.87 |
| Relative Strength Index (RSI) | 63.30 |
| Average Volume (20 Days) | 1,965,948 |
Short Selling Information
The latest short interest is 21.93 million, so 12.72% of the outstanding shares have been sold short.
| Short Interest | 21.93M |
| Short Previous Month | 22.64M |
| Short % of Shares Out | 12.72% |
| Short % of Float | 21.38% |
| Short Ratio (days to cover) | 12.78 |
Income Statement
In the last 12 months, RLAY had revenue of $8.36 million and -$311.55 million in losses. Loss per share was -$1.92.
| Revenue | 8.36M |
| Gross Profit | -267.97M |
| Operating Income | -340.77M |
| Pretax Income | -311.55M |
| Net Income | -311.55M |
| EBITDA | -335.85M |
| EBIT | -340.77M |
| Loss Per Share | -$1.92 |
Full Income StatementBalance Sheet
The company has $656.78 million in cash and $34.18 million in debt, giving a net cash position of $622.59 million or $3.61 per share.
| Cash & Cash Equivalents | 656.78M |
| Total Debt | 34.18M |
| Net Cash | 622.59M |
| Net Cash Per Share | $3.61 |
| Equity (Book Value) | 665.66M |
| Book Value Per Share | 3.88 |
| Working Capital | 647.87M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$261.42 million and capital expenditures -$637,000, giving a free cash flow of -$262.06 million.
| Operating Cash Flow | -261.42M |
| Capital Expenditures | -637,000 |
| Free Cash Flow | -262.06M |
| FCF Per Share | -$1.52 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -4,078.58% |
| Pretax Margin | -3,728.89% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
RLAY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -26.88% |
| Shareholder Yield | -26.88% |
| Earnings Yield | -25.31% |
| FCF Yield | -21.29% |
Dividend DetailsAnalyst Forecast
The average price target for RLAY is $17.25, which is 141.60% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $17.25 |
| Price Target Difference | 141.60% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 59.30% |
| EPS Growth Forecast (5Y) | -9.59% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
RLAY has an Altman Z-Score of 3.33 and a Piotroski F-Score of 2.
| Altman Z-Score | 3.33 |
| Piotroski F-Score | 2 |
